01Key Responsibilities
Analyze the pharma market to identify gaps and opportunities, especially in the innovative space. Prepare market performance overview for Glenmarks competition for all dosage forms. Generate ideas of high value for proprietary products for Glenmark in global markets. Evaluate new unique opportunities using multiple databases and recommend potential additions to the portfolio. Conduct risk assessments of the existing portfolio with suitable mitigation strategies. Prepare business cases using standard forecasting tools for investments in product or portfolio acquisition with inputs from business and Product Development teams for in-house and in-licensed assets. Support the regional portfolio leads in preparing product grids for the next five years with high potential peak sales, factoring in complexity of various stakeholders like R&D, RA, Manufacturing, Clinical, and IP. Ensure the selected grid remains relevant and in good standing through regular reviews. Knowledge and Skills:
Forecasting for NCE, generic, and differentiated generic products. Ability to incorporate qualitative inputs into quantitative models. Understanding of market access, reimbursement, and competitive environment in major markets. Portfolio experience and strong medical knowledge in various therapy areas, especially in Dermatology, Respiratory, and Oncology. Strong communication, negotiation, and influencing skills. Expertise in business analytics and planning for short- and medium-term strategies. Good understanding of business operations management. Identification of new innovative/specialty/505(b)(2) opportunities. (Optional) Understanding of current regulatory processes for relevant markets. Knowledge of IP issues in pharmaceuticals, including Hatch-Waxman Act. Strong CMC knowledge for various dosage forms, including oral solids, injectables, and dermatology products. Application Process:
Interested candidates can apply by sending their resume and application form to Sagar.Goswami@glenmarkpharma.com with the subject line "Application for Head Analytics & Competitive Intelligence" latest by 14th February 2025. .
